Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Karin Patocka"'
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 3, Pp 624-627 (2021)
Abstract Dupilumab is a monoclonal antibody against the IL‐4 receptor alpha which has shown efficacy in T2 high severe asthmatics in phase 3 randomized controlled trials. The purpose of this real‐life study is to demonstrate the real‐life effec
Externí odkaz:
https://doaj.org/article/0d1876e1ad004b49aabbb18c3bf05ccb
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/e3e68264d6d04b7da20e06080dc2d0fd
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 3, Pp 624-627 (2021)
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease
Dupilumab is a monoclonal antibody against the IL‐4 receptor alpha which has shown efficacy in T2 high severe asthmatics in phase 3 randomized controlled trials. The purpose of this real‐life study is to demonstrate the real‐life effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af8f2ce802bd01b94f4ad5ffc698d7b
https://doaj.org/article/0d1876e1ad004b49aabbb18c3bf05ccb
https://doaj.org/article/0d1876e1ad004b49aabbb18c3bf05ccb
Publikováno v:
Airway pharmacology and treatment.
Background: Efficacy of mepolizumab in severe eosinophilic asthma has been demonstrated in large randomized controlled trials (RCTs) but patients included in RCTs poorly reflect real-life patients. Objectives: The objective was to investigate whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fe878baad5e5f2ccaa53dba10aa221d
https://doi.org/10.1183/13993003.congress-2020.2229
https://doi.org/10.1183/13993003.congress-2020.2229
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
ERJ Open Research
article-version (AM) Accepted Manuscript
ERJ Open Research
article-version (AM) Accepted Manuscript
Amidst the current pandemic there is only little clinical evidence regarding COVID-19 infections in asthma patients. Chinese data [1, 2] suggests that asthma patients might not be of an elevated risk of severe infections. A recent article by Carli et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b57a95b75ff9c997787e7849f758746
https://pubmed.ncbi.nlm.nih.gov/33257916
https://pubmed.ncbi.nlm.nih.gov/33257916
Publikováno v:
Pulmonary pharmacologytherapeutics. 64
Mepolizumab was effective in several randomized clinical trials (RCTs) in patients with severe eosinophilic asthma, but evidence for symptom control in a real-world population is scarce.To assess asthma symptom control, lung function, use of oral cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75aaff55a0c59ce0d80ce2262749b838
https://pubmed.ncbi.nlm.nih.gov/32949705
https://pubmed.ncbi.nlm.nih.gov/32949705
Publikováno v:
Allergy. 75(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ba62d31c35449d0ed483e7fbb868dd
https://pubmed.ncbi.nlm.nih.gov/32526056
https://pubmed.ncbi.nlm.nih.gov/32526056
Publikováno v:
American Journal of Human Biology. 25:847-850
Objectives Relative body weight is not only an important indicator for health and reproductive condition, but also subject to stereotypes and stigmatization. It can be reliably assessed from adult faces alone, yet the facial correlates, especially in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63fd0168d3af439fb7628c6c1f6df36b
https://doi.org/10.1002/ajhb.22444
https://doi.org/10.1002/ajhb.22444